Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciliberto

Showing results (561-570 of 839) with videos related to

Pageof 84
Sort By:
Journal of Biomedical Informatics|May 20, 2023
Development of a somatic variant registry in a National Cancer Center: towards Molecular Real World Data preparednessMartina Betti, Chiara Maria Salzano, Alice Massacci, et al.
Cell Death & Disease|March 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitorsDomenico Liguoro, Rachele Frigerio, Arianna Ortolano, et al.
The EMBO Journal|October 4, 2021
Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerizationMattia Pavani, Paolo Bonaiuti, Elena Chiroli, et al.
Immunity|March 1, 1997
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitmentM Romano, M Sironi, C Toniatti, et al.
The EMBO Journal|October 2, 1998
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liverD Maione, E Di Carlo, W Li, et al.
Immunity|February 19, 1999
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cellsR Catlett-Falcone, T H Landowski, M M Oshiro, et al.
Oncotarget|February 11, 2016
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expressionChiara Ciardiello, Maria Serena Roca, Alessia Noto, et al.
BMC Cancer|October 18, 2015
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control studyMaurizio Montella, Matteo Di Maso, Anna Crispo, et al.
Scientific Reports|May 4, 2017
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic SarcomasMaria Vincenza Carriero, Katia Bifulco, Vincenzo Ingangi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2023
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinomaFilippo Tommaso Gallina, Riccardo Tajè, Fabiana Letizia Cecere, et al.
Pageof 84

Showing results (561-570 of 839) with videos related to

Sort By:
Pageof 84
Journal of Biomedical Informatics|May 20, 2023
Development of a somatic variant registry in a National Cancer Center: towards Molecular Real World Data preparednessMartina Betti, Chiara Maria Salzano, Alice Massacci, et al.
Cell Death & Disease|March 13, 2024
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitorsDomenico Liguoro, Rachele Frigerio, Arianna Ortolano, et al.
The EMBO Journal|October 4, 2021
Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerizationMattia Pavani, Paolo Bonaiuti, Elena Chiroli, et al.
Immunity|March 1, 1997
Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitmentM Romano, M Sironi, C Toniatti, et al.
The EMBO Journal|October 2, 1998
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liverD Maione, E Di Carlo, W Li, et al.
Immunity|February 19, 1999
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cellsR Catlett-Falcone, T H Landowski, M M Oshiro, et al.
Oncotarget|February 11, 2016
Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expressionChiara Ciardiello, Maria Serena Roca, Alessia Noto, et al.
BMC Cancer|October 18, 2015
Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control studyMaurizio Montella, Matteo Di Maso, Anna Crispo, et al.
Scientific Reports|May 4, 2017
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic SarcomasMaria Vincenza Carriero, Katia Bifulco, Vincenzo Ingangi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2023
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinomaFilippo Tommaso Gallina, Riccardo Tajè, Fabiana Letizia Cecere, et al.
Pageof 84